Targeting hormone receptors reduces lupus-related kidney damage in mice

Researchers at the University of California, Riverside, and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues. By targeting an imbalance in receptors for the hormone prolactin in disease-causing immune cells, the team reduced inflammatory molecules and harmful immune cells while preserving their normal counterparts.

Read it at Medical Xpress ↗

← Front page